🚨Exciting News! #JSCAI is accepted for PubMed Central Indexing!🎉
Read @AlexandraLansky's editorial:
➡️https://t.co/eQVlmXEXYV
📢This significant milestone boosts our authors' visibility, citation rates, and recognition by making all articles more accessible to researchers and practitioners.
♥️Thank you to our Editors, Authors, Reviewers, and everyone for their unwavering support in making this possible. @SCAI
When you’re one of the few, 2.2% hits differently
As a woman performing TAVR & M-TEER in community practice, this resonates deeply
Grateful for our team @DoylestownHlth
May these statistics become history for the next generation!
https://t.co/VErOpcZXZJ
#WIC#StructuralHeart
Preservation of Distal Cap Bifurcation in Chronic Total Occlusion by Tip-Detection Antegrade Dissection Re-entry Method: A Retrospective Analysis of 77 Patients https://t.co/3hFcJMQlGQ @MyJSCAI
In a study including 546-patient real Heart Team discussions, LLMs showed moderate agreement with expert clinical decisions, but only when they received detailed, context-rich clinical narrative input https://t.co/2Ain0aYJEX @MyJSCAI
📣The October issue of #JSCAI is now available!
Explore research on catheter-based cardiovascular procedures, coronary and structural heart interventions, clinical outcomes, and emerging techniques. Open access and designed for today's interventional cardiologist.
Read the full issue ➡️ https://t.co/whfdWtGF7J
#InterventionalCardiology #Cardiology @MyJSCAI
📖 New research from the TRANSFORM I substudy shows that #OCT-detected suspected intraluminal thrombus (SIT) before #drugcoatedballoon angioplasty was linked to worse 6-month angiographic outcomes, including higher rates of binary restenosis.
➡️https://t.co/nSz0LPQkVT
@Antocol17
#DCB
🆕🗣️Late-breaking clinical trial presented at #VIVA2026 & published in #JSCAI: 9-month AGILITY Study results support the safety & effectiveness of Revello, a novel self-expanding covered stent, for the treatment of #IliacArterialDisease.
➡️https://t.co/aQIE4g8TTk
@nicolas_shammas
📖Among patients with #afib & #chronickidneydisease, this real-world analysis showed #LAAO was associated with decreased all-cause mortality compared to direct oral #anticoagulants, however there was no improvement in intermediate outcomes. These findings are hypothesis generating. Read more:
➡️https://t.co/61SuAJLAed
@_ottun@maxflare@CChinatambi@wazza_233
Excellent statement on the journey so far and path forward toward interventional heart failure (IHF) as a discipline. Worth a read.
Link: https://t.co/4IV8p40PZ3
Title ⬇️
Interventional cardiology or heart failure? Both. Grateful to have led this work with my coauthors on the future of training.
https://t.co/aJwaei4MBI
@MyJSCAI
📖Could drug-coated balloons become a novel strategy for stabilizing vulnerable plaques? Comprehensive review of vulnerable plaque detection, preventive PCI, & the emerging role of drug-coated balloons. #VulnerablePlaque #PCI #DCB Read now in #JSCAI
➡️https://t.co/5NlMTfRvr2
@BimmerClaessen@hect2701
The September issue of @MyJSCAI is now available. Explore new research, meta-analyses, and case reports covering cardiogenic shock, structural heart interventions, LAAO, and more. Open access and designed for today's interventional cardiologist.
Explore the issue ➡️ https://t.co/2F2MaDpsSQ
#InterventionalCardiology
🫀Excited to share our work, now published in @JSCAI!
❓Do women and men with severe MR experience different delays in reaching the structural heart team?
➡️We looked at referral timing among patients undergoing M-TEER @DeBakeyCVedu 🧵
https://t.co/bddBDycSl4
📖LAAO vs OAC in AF: Bayesian meta-analysis of 6 RCTs (7,004 pts). High probability #LAAO↑ ischemic stroke, but absolute risk small & offset by↓ hemorrhagic stroke. #AFib
➡️https://t.co/eVRJHqcvxq
@jaygirimd